Federal Initiatives for Pricing Transparency

RSVP Here.

As the election nears and with the recent flurry of regulatory activity surrounding drug pricing transparency, bio/pharma manufacturers must continuously stay ahead of the ever-evolving changes. Join Arent Fox Senior Attorney Erin E. Atkins at Informa Connect’s 6th Edition Drug Pricing Transparency Congress to discuss the following:

• Updates on the status of proposed bills and rules to date and discuss the impact on the industry  
• How federal regulations will impact state regulations
• Review of what’s next for any drug pricing transparency initiatives on the Hill
• The 2020 campaign and candidates’ views on drug pricing transparency
• The status of the International Pricing Index Model and its impact on transparency issues

RSVP Here